Condition

Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer (1)

Breast Cancer (1)

Dyslipidemia (1)

Epithelial Ovarian Cancer (1)

Fallopian Tube Cancer (1)

Ovarian Cancer (1)

Peritoneal Cancer (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Completed (1)

Phase

n/a (1)

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

Clovis Oncology, Inc. (1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)

Institute for Clinical Effectiveness and Health Policy (1)

University of South Carolina (1)

Collaborator

Foundation Medicine (2)

Istituto Di Ricerche Farmacologiche Mario Negri (1)

Intervention

rucaparib (2)

bevacizumab (1)

carboplatin (1)

chemotherapy (1)

educational intervention (1)

no intervention (1)

paclitaxel (1)

Study Documents

Intervention Type

drug (2)

other (2)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (3)

Observational (1)

ruca

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer Trial in Italy (Carboplatin, Paclitaxel,

Recruiting

Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Carboplatin
+3 more

Legnago, Italy
+6 more

Aug 24, 2021

Young Breast Cancer Survivors Study

Recruiting

Breast Cancer

No intervention

Columbia, South Carolina

University of South Carolina

Aug 9, 2023

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Chemotherapy, Rucaparib)

Active, not recruiting

Has Results

Ovarian Cancer
+3 more

Denver, Colorado
+76 more

Feb 20, 2022

Dyslipidemia Trial in Argentina (Educational Intervention)

Completed

Dyslipidemia

Educational Intervention

Puerto Madryn, Chubut, Argentina
+9 more

Aug 14, 2017